IDEXX Laboratories Inc (IDXX)
Working capital turnover
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 3,897,506 | 3,844,819 | 3,784,803 | 3,724,853 | 3,660,953 | 3,587,920 | 3,514,054 | 3,430,970 | 3,367,324 | 3,339,846 | 3,308,606 | 3,274,202 | 3,215,360 | 3,135,208 | 3,046,576 | 2,858,026 | 2,706,655 | 2,591,163 | 2,474,677 | 2,457,188 |
Total current assets | US$ in thousands | 1,399,900 | 1,433,740 | 1,528,610 | 1,501,970 | 1,495,250 | 1,384,230 | 1,179,020 | 1,149,450 | 1,101,480 | 1,058,860 | 1,042,820 | 1,089,770 | 955,655 | 938,037 | 1,001,230 | 1,097,800 | 1,062,740 | 868,679 | 779,612 | 721,351 |
Total current liabilities | US$ in thousands | 1,067,920 | 1,009,220 | 1,116,700 | 956,902 | 951,547 | 970,193 | 883,859 | 1,065,630 | 1,235,800 | 1,189,940 | 1,166,550 | 971,341 | 763,579 | 633,849 | 651,809 | 620,662 | 582,761 | 526,841 | 540,584 | 846,241 |
Working capital turnover | 11.74 | 9.06 | 9.19 | 6.83 | 6.73 | 8.67 | 11.91 | 40.93 | — | — | — | 27.65 | 16.74 | 10.31 | 8.72 | 5.99 | 5.64 | 7.58 | 10.35 | — |
December 31, 2024 calculation
Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $3,897,506K ÷ ($1,399,900K – $1,067,920K)
= 11.74
IDEXX Laboratories Inc's working capital turnover ratio demonstrates the efficiency with which the company is utilizing its working capital to generate sales revenue. From the provided data, we observe fluctuations in the working capital turnover ratio over the years.
- The working capital turnover ratio for IDEXX Laboratories Inc was not available for March 31, 2020, June 30, 2022, and September 30, 2022, indicating potential missing or unreported data points.
- The ratio decreased from 10.35 on June 30, 2020, to 5.64 on December 31, 2020, suggesting a decline in the company's ability to efficiently convert working capital into revenue during this period.
- Subsequently, there was a gradual improvement in the ratio, reaching 16.74 on December 31, 2021, indicating a significant increase in efficiency in utilizing working capital to generate sales.
- The trend continued to improve as the ratio surged to 40.93 on March 31, 2023, reflecting a substantial enhancement in the company's working capital management.
- However, the ratio dropped to 6.83 on March 31, 2024, displaying a reduction in efficiency compared to the prior quarter.
- The working capital turnover ratio thereafter showed fluctuations between 6.73 and 11.74 in the following quarters, indicating varying degrees of efficiency in utilizing working capital to drive sales revenue.
In conclusion, the working capital turnover ratio for IDEXX Laboratories Inc fluctuated over the years, with periods of significant improvements and occasional declines in efficiency in converting working capital into sales revenue.
Peer comparison
Dec 31, 2024